RECENT NEWS

Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk of a heart attack or other major cardiovascular event.

Waters Corporation has announced it has completed the previously announced combination with the biosciences and diagnostic solutions businesses of Becton, Dickinson and Company (BD).

As preparations for the London Biotechnology Show 2026 continue to gain momentum, Early Bird registrations are now entering their final days. With just a few days remaining, this is the last opportunity to secure delegate access at reduced rates.

Scripps Research scientists have designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus.

UC San Diego biologists have developed a new CRISPR-based technology capable of removing antibiotic-resistant elements from populations of bacteria.

The Government has unveiled its landmark National Cancer Plan, which promises patients will receive faster diagnosis, quicker treatment and the support to live well with cancer.

Aiforia Technologies has announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR.

A research team from Université de Genève has revealed how the 'hijacking' of neutrophils promotes cancer growth and could provide insights into disease progression.

An innovative bowel cancer screening test created in the north east is now being rolled out for patients elsewhere in the country.

The iFAST ONE ultra-rapid Antimicrobial Susceptibility Test (AST) system is now UKCA Certified for testing patient samples, direct from Gram-negative bacteria blood cultures.

The government has accepted advice on eligibility from the Joint Committee on Vaccination and Immunisation (JCVI) for the respiratory syncytial virus (RSV) vaccination programme.

The Institute of Cancer Research, London, is the joint recipient of a major new Medical Research Council (MRC) grant to advance how sensitive medical imaging data can be used for research.

The Association for Diagnostics & Laboratory Medicine (ADLM) has launched a new Data Science in Laboratory Medicine Certificate Programme, designed to help clinical laboratory professionals and pathologists use healthcare data to solve challenging patient problems.

BD (Becton, Dickinson and Company) and Envetec Sustainable Technologies have announced the successful completion of a joint feasibility study to test the ability to recycle polystyrene Petri dishes into new, high-quality manufacturing feedstock.

Registration for the British Society For Microbial Technology’s 41st Annual Microbiology Conference is open now. The event takes place on Thursday 21 May, at North London’s RAF Museum, Hendon.

Una Health has announced a new partnership with Forte Medical to support the distribution of the Peezy urine collection device across the UK, strengthening efforts to improve urine sample quality and diagnostic accuracy within NHS care pathways.

With an ever-increasing demand for faster sterility testing solutions, Alpha Laboratories is pleased to introduce the new RiboNAT rapid sterility test by FUJIFILM Wako.

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson’s disease in its earliest stages, before extensive brain damage has occurred.

Beckman Coulter Life Sciences and Automata have announced a strategic partnership that integrates Beckman Coulter Life Sciences liquid handling, genomic and cell analysis technologies with Automata’s AI-ready automation platform to enable faster, more consistent and more scalable experimentation for research organisations.

En Carta Diagnostics, a Paris-based start-up developing rapid point-of-need molecular diagnostics kits, has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its EC Pocket Lyme.